There is a regulatory update on the 2026 Drugs to Watch. Several developments are expected, including FDA decisions and potential changes to policies on various drugs, although some reports suggest regulatory delays and staff issues may impact the process. The specific outcomes and details of these updates are unclear, with multiple factors and changes potentially affecting the regulatory landscape.